{"url_path":"/sec/ivf/10-q/2026/item-5","section_key":"item-5","section_title":"Item 5 Other Information**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-06-22","source_url":"https://www.sec.gov/Archives/edgar/data/1417926/0001493152-26-029514-index.html","accession_number":"0001493152-26-029514","cik":"0001417926","ticker":"IVF","issuer_name":"INVO Fertility, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1417926/0001493152-26-029514-index.html","primary_entity_key":"0001417926","primary_entity_name":"INVO Fertility, Inc."},"word_count":61,"has_tables":true,"body_markdown":"**Item\n5. Other Information**\n\n \n\n(a)\nNone.\n\n \n\n(b)\nNone.\n\n \n\n(c)\n**Insider\nAdoption or Termination of Trading Arrangements**\n\n \n\nDuring\nthe fiscal quarter ended March 31, 2026, none of our directors or officers informed us of the adoption, modification, or termination\nof a Rule 10b5-1 trading arrangement or non-Rule 10b5-1 trading arrangement, as such terms are defined in Item 408 of Regulation S-K.\n\n \n\n39"}